Search Results - "DeMatteo, Ronald P"

Nomograms in oncology: more than meets the eye by Balachandran, Vinod P, Dr, Gonen, Mithat, PhD, Smith, J Joshua, MD, DeMatteo, Ronald P, MD

“…Summary Nomograms are widely used as prognostic devices in oncology and medicine. With the ability to generate an individual probability of a clinical event by…”
Get full text

ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity by Moral, John Alec, Leung, Joanne, Rojas, Luis A., Ruan, Jennifer, Zhao, Julia, Sethna, Zachary, Ramnarain, Anita, Gasmi, Billel, Gururajan, Murali, Redmond, David, Askan, Gokce, Bhanot, Umesh, Elyada, Ela, Park, Youngkyu, Tuveson, David A., Gönen, Mithat, Leach, Steven D., Wolchok, Jedd D., DeMatteo, Ronald P., Merghoub, Taha, Balachandran, Vinod P.

“…Group 2 innate lymphoid cells (ILC2s) regulate inflammation and immunity in mammalian tissues 1 , 2 . Although ILC2s are found in cancers of these tissues 3 ,…”
Get full text

The Management of Gastrointestinal Stromal Tumors: A Model for Targeted and Multidisciplinary Therapy of Malignancy by Joensuu, Heikki, DeMatteo, Ronald P

“…Gastrointestinal stromal tumor (GIST) has become a model for targeted therapy in cancer. The vast majority of GISTs contain an activating mutation in either…”
Get full text

Bile leakage after hepatobiliary and pancreatic surgery: A definition and grading of severity by the International Study Group of Liver Surgery by Koch, Moritz, MD, Garden, O. James, MD, Padbury, Robert, MD, Rahbari, Nuh N., MD, Adam, Rene, MD, Capussotti, Lorenzo, MD, Fan, Sheung Tat, MD, Yokoyama, Yukihiro, MD, Crawford, Michael, MD, Makuuchi, Masatoshi, MD, Christophi, Christopher, MD, Banting, Simon, MD, Brooke-Smith, Mark, MD, Usatoff, Val, MD, Nagino, Masato, MD, Maddern, Guy, MD, Hugh, Thomas J., MD, Vauthey, Jean-Nicolas, MD, Greig, Paul, MD, Rees, Myrddin, MD, Nimura, Yuji, MD, Figueras, Joan, MD, DeMatteo, Ronald P., MD, Büchler, Markus W., MD, Weitz, Jürgen, MD

“…Background Despite the potentially severe impact of bile leakage on patients’ perioperative and long-term outcome, a commonly used definition of this…”
Get full text

Actual 10-year survival after hepatic resection of colorectal liver metastases: what factors preclude cure? by Creasy, John M., Sadot, Eran, Koerkamp, Bas Groot, Chou, Joanne F., Gonen, Mithat, Kemeny, Nancy E., Balachandran, Vinod P., Kingham, T. Peter, DeMatteo, Ronald P., Allen, Peter J., Blumgart, Leslie H., Jarnagin, William R., D'Angelica, Michael I.

“…Hepatic resection of colorectal liver metastases is associated with long-term survival. This study analyzes actual 10-year survivors after resection of…”
Get full text

Distal Pancreatectomy: A Single Institution's Experience in Open, Laparoscopic, and Robotic Approaches by Lee, Ser Yee, MBBS, MSc, MMed, FRCS(Ed), Allen, Peter J., MD, FACS, Sadot, Eran, MD, D’Angelica, Michael I., MD, FACS, DeMatteo, Ronald P., MD, FACS, Fong, Yuman, MD, FACS, Jarnagin, William R., MD, FACS, Kingham, T. Peter, MD, FACS

“…Background The indications for minimally invasive (MIS) pancreatectomy have slowly increased as experience, techniques, and technology have improved and…”
Get full text

Genetic Determinants of Outcome in Intrahepatic Cholangiocarcinoma by Boerner, Thomas, Drill, Esther, Pak, Linda M., Nguyen, Bastien, Sigel, Carlie S., Doussot, Alexandre, Shin, Paul, Goldman, Debra A., Gonen, Mithat, Allen, Peter J., Balachandran, Vinod P., Cercek, Andrea, Harding, James, Solit, David B., Schultz, Nikolaus, Kundra, Ritika, Walch, Henry, D’Angelica, Michael I., DeMatteo, Ronald P., Drebin, Jeffrey, Kemeny, Nancy E., Kingham, T. Peter, Simpson, Amber L., Hechtman, Jaclyn F., Vakiani, Efsevia, Lowery, Maeve A., Ijzermans, J.N.M., Buettner, S., Koerkamp, B. Groot, Doukas, M., Chandwani, Rohit, Jarnagin, William R.

“…Background and Aim Genetic alterations in intrahepatic cholangiocarcinoma (iCCA) are increasingly well characterized, but their impact on outcome and prognosis…”
Get full text

Postoperative Mortality after Liver Resection for Perihilar Cholangiocarcinoma: Development of a Risk Score and Importance of Biliary Drainage of the Future Liver Remnant by Wiggers, Jimme K., MD, PhD, Koerkamp, Bas Groot, MD, PhD, Cieslak, Kasia P., MD, Doussot, Alexandre, MD, van Klaveren, David, PhD, Allen, Peter J., MD, FACS, Besselink, Marc G., MD, PhD, Busch, Olivier R., MD, PhD, D’Angelica, Michael I., MD, FACS, DeMatteo, Ronald P., MD, FACS, Gouma, Dirk J., MD, PhD, Kingham, T Peter, MD, FACS, van Gulik, Thomas M., MD, PhD, Jarnagin, William R., MD, FACS

“…Abstract Background Liver surgery for perihilar cholangiocarcinoma (PHC) is associated with postoperative mortality ranging from 5% to 18%. The aim of this…”
Get full text

Intraductal papillary neoplasm of the bile duct: A biliary equivalent to intraductal papillary mucinous neoplasm of the pancreas? by Rocha, Flavio G., Lee, Hwajeong, Katabi, Nora, DeMatteo, Ronald P., Fong, Yuman, D'Angelica, Michael I., Allen, Peter J., Klimstra, David S., Jarnagin, William R.

“…Intraductal papillary neoplasm of the bile duct (IPNB) is a variant of bile duct carcinoma characterized by intraductal growth and better outcome compared with…”
Get full text

Recurrence Patterns and Disease-Free Survival after Resection of Intrahepatic Cholangiocarcinoma: Preoperative and Postoperative Prognostic Models by Doussot, Alexandre, MD, Gonen, Mithat, PhD, Wiggers, Jimme K., MD, PhD, Groot-Koerkamp, Bas, MD, PhD, DeMatteo, Ronald P., MD, FACS, Fuks, David, MD, PhD, Allen, Peter J., MD, FACS, Farges, Olivier, MD, PhD, Kingham, T Peter, MD, FACS, Regimbeau, Jean Marc, MD, PhD, D'Angelica, Michael I., MD, FACS, Azoulay, Daniel, MD, PhD, Jarnagin, William R., MD, FACS

“…Background Liver resection is the most effective treatment for intrahepatic cholangiocarcinoma. Recurrent disease is frequent; however, recurrence patterns are…”
Get full text

Hepatic Parenchymal Preservation Surgery: Decreasing Morbidity and Mortality Rates in 4,152 Resections for Malignancy by Kingham, T. Peter, MD, FACS, Correa-Gallego, Camilo, MD, D’Angelica, Michael I., MD, FACS, Gönen, Mithat, PhD, DeMatteo, Ronald P., MD, FACS, Fong, Yuman, MD, FACS, Allen, Peter J., MD, FACS, Blumgart, Leslie H., MD, FACS, Jarnagin, William R., MD, FACS

“…Background Liver resection is used to treat primary and secondary malignancies. Historically, these procedures were associated with significant complications,…”
Get full text

Recurrence Rate and Pattern of Perihilar Cholangiocarcinoma after Curative Intent Resection by Groot Koerkamp, Bas, MD, PhD, Wiggers, Jimme K., MD, Allen, Peter J., MD, FACS, Besselink, Marc G., MD, PhD, Blumgart, Leslie H., MD, FACS, Busch, Olivier R.C., MD, PhD, Coelen, Robert J., MD, D'Angelica, Michael I., MD, FACS, DeMatteo, Ronald P., MD, FACS, Gouma, Dirk J., MD, PhD, Kingham, T. Peter, MD, FACS, Jarnagin, William R., MD, FACS, van Gulik, Thomas M., MD, PhD

“…Background The aim of this study was to investigate the rate and pattern of recurrence after curative intent resection of perihilar cholangiocarcinoma (PHC)…”
Get full text

Survival after Hepatic Resection for Metastatic Colorectal Cancer: Trends in Outcomes for 1,600 Patients during Two Decades at a Single Institution by House, Michael G., MD, Ito, Hiromichi, MD, Gönen, Mithat, PhD, Fong, Yuman, MD, FACS, Allen, Peter J., MD, FACS, DeMatteo, Ronald P., MD, FACS, Brennan, Murray F., MD, FACS, Blumgart, Leslie H., MD, FACS, Jarnagin, William R., MD, FACS, D'Angelica, Michael I., MD, FACS

“…Background This study analyzes factors associated with differences in long-term outcomes after hepatic resection for metastatic colorectal cancer over time…”
Get full text

Actual 10-Year Survival After Resection of Colorectal Liver Metastases Defines Cure by TOMLINSON, James S, JARNAGIN, William R, DEMATTEO, Ronald P, YUMAN FONG, KORNPRAT, Peter, GONEN, Mithat, KEMENY, Nancy, BRENNAN, Murray F, BLUMGART, Leslie H, D'ANGELICA, Michael

“…Resection of colorectal liver metastases (CLM) in selected patients has evolved as the standard of care during the last 20 years. In the absence of prospective…”
Get full text

Observation versus Resection for Small Asymptomatic Pancreatic Neuroendocrine Tumors: A Matched Case–Control Study by Sadot, Eran, Reidy-Lagunes, Diane L., Tang, Laura H., Do, Richard Kinh Gian, Gonen, Mithat, D’Angelica, Michael I., DeMatteo, Ronald P., Kingham, T. Peter, Koerkamp, Bas Groot, Untch, Brian R., Brennan, Murray F., Jarnagin, William R., Allen, Peter J.

“…Objective To analyze the natural history of small asymptomatic pancreatic neuroendocrine tumors (PanNET) and to present a matched comparison between groups who…”
Get full text

Survival Prediction in Pancreatic Ductal Adenocarcinoma by Quantitative Computed Tomography Image Analysis by Attiyeh, Marc A., Chakraborty, Jayasree, Doussot, Alexandre, Langdon-Embry, Liana, Mainarich, Shiana, Gönen, Mithat, Balachandran, Vinod P., D’Angelica, Michael I., DeMatteo, Ronald P., Jarnagin, William R., Kingham, T. Peter, Allen, Peter J., Simpson, Amber L., Do, Richard K.

“…Background Pancreatic cancer is a highly lethal cancer with no established a priori markers of survival. Existing nomograms rely mainly on post-resection data…”
Get full text

Actual 10-Year Survivors After Resection of Hepatocellular Carcinoma by Zheng, Jian, Kuk, Deborah, Gönen, Mithat, Balachandran, Vinod P., Kingham, T. Peter, Allen, Peter J., D’Angelica, Michael I., Jarnagin, William R., DeMatteo, Ronald P.

“…Background Resection of hepatocellular carcinoma (HCC) offers a chance of cure, but recurrence is common and survival is often limited. The clinical and…”
Get full text

Surgical Management of Germline Gastrointestinal Stromal Tumor by Kwak, Hyunjee V., Tardy, Katherine J., Allbee, Andrew, Stashek, Kristen, DeMatteo, Ronald P.

“…Gastrointestinal stromal tumor (GIST) is the most common human sarcoma and usually results from a sporadic mutation in KIT or, less frequently,…”
Get full text

Survival after Resection of Pancreatic Adenocarcinoma: Results from a Single Institution over Three Decades by Winter, Jordan M., Brennan, Murray F., Tang, Laura H., D’Angelica, Michael I., DeMatteo, Ronald P., Fong, Yuman, Klimstra, David S., Jarnagin, William R., Allen, Peter J.

“…Background Randomized trials have demonstrated a benefit associated with adjuvant therapy for pancreatic cancer, and retrospective studies have demonstrated…”
Get full text

Postoperative complications and overall survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma by Pugalenthi, Amudhan, Protic, Mladjan, Gonen, Mithat, Kingham, T. Peter, Angelica, Michael I.D'., Dematteo, Ronald P., Fong, Yuman, Jarnagin, William R., Allen, Peter J.

“…Introduction Pancreaticoduodenectomy (PD) performed for pancreatic ductal adenocarcinoma (PDA) has a postoperative morbidity of 40–50%. In this study, we…”
Get full text